Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| GNTA | Genenta Science S.p.A. | $3.48 | -$2.72 | -43.87% | 1.3M | $118.7M | $2.56$10.00 |
| NTLA | Intellia Therapeutics | $14.50 | -$11.10 | -43.36% | 37.3M | $2.7B | $5.90$28.25 |
| SLGB | Smart Logistics Global | $2.90 | -$2.20 | -43.14% | 7.4M | $209.1M | $2.42$6.08 |
| IRBT | iRobot | $3.98 | -$1.60 | -28.67% | 280.6K | $175.0M | $1.76$13.06 |
| PRE | Prenetics Global | $12.67 | -$4.09 | -24.40% | 576.3K | $218.4M | $3.09$17.99 |
| OGN | Organon & Co. | $7.10 | -$2.06 | -22.49% | 993K | $2.4B | $6.81$19.05 |
| FLWS | 1-800-Flowers.com | $3.79 | -$1.08 | -22.18% | 70.8K | $309.8M | $3.76$9.24 |
| NEUP | Neuphoria Therapeutics | $4.99 | -$1.25 | -20.03% | 1.8M | $11.7M | $2.12$21.40 |
| NBTX | Nanobiotix | $15.40 | -$3.80 | -19.79% | 131.7K | $920.1M | $2.76$30.35 |
| CYCU | Cycurion | $3.88 | -$0.92 | -19.17% | 439K | $339.6M | $3.80$2,045.10 |
Related Articles
Featured Article
1 Reason Why NioCorp Could Quietly Power the AI Revolution
Howard Smith|Oct 22, 2025
Should you take advantage of the 30% pullback in this critical mineral development company?
Is the White House About to Invest in These Lithium and Rare Earth Miners?
Matthew Benjamin|Oct 12, 2025
The U.S. government may be eyeing investments in mining companies, sending their shares higher.
1 Stock Up by 63% This Year That Could Double, According to Wall Street
Prosper Junior Bakiny|Oct 7, 2025
Some math suggests that even Wall Street is lowballing the stock's potential.
2 Incredible Growth Stocks to Buy With $1,000
George Budwell|Sep 27, 2025
One stock has soared 173% this year on momentum from critical minerals, while the other is down 23% despite growing revenue in the mid-teens annually.
Down 33% in 1 Month, Should You Buy the Dip With Intellia Therapeutics Stock?
Alex Carchidi|Nov 22, 2024
Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?
Alex Carchidi|Nov 6, 2024
There's nothing bearish at all about what it reported recently.
This Beaten-Down Stock Could Soar by 354%, According to Wall Street
Prosper Junior Bakiny|Nov 4, 2024
Maybe the Street is a bit too optimistic on this one.
This Beaten-Down Growth Stock Could Skyrocket 234%, According to Wall Street
George Budwell|Oct 17, 2024
Intellia Therapeutics' innovative gene editing technology could revolutionize medicine, but investors need a strong stomach for volatility.
2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk
Alex Carchidi|Sep 29, 2024
The Ark Invest portfolio is known for taking aggressive bets.
iRobot Is a Falling Knife That's Too Risky for Most
Joseph Arroyo|Jul 23, 2024
iRobot's faces a looming cash-flow crunch.
